Symbols

APVO

Aptevo Therapeutics·NASDAQ

--(--)

7.64 / 10

Outperform

Sentiment score is 7.64 (Outperform) and fund‑flow rating is bullish, with overall inflow ratios around 0.49 across size categories, though trends are labeled negative. Analyst evaluation is unavailable, but money‑flow sentiment remains positive.

Fund Flow Rating

Is money flowing into or out of APVO?

APVO holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.64/10 (Outperform).